Could we be soon be producing the next generation of anti-cancer drugs in tobacco?
SCMB’s Dr Michael Landsberg is part of a group that is aiming to do just that.
Together with colleagues from the Australian Institute for Bioengineering and Nanotechnology, Dr Landsberg’s group show that nanoparticles produced in the leaves of the tobacco plant Nicotiana benthamiana can be used to encapsulate small molecules and proteins and deliver them to cells.
Their results pave the way for the use of similar strategies to direct therapeutic molecules to diseased cells, which could find value in the treatment of cancer and other diseases.
Their latest findings have been published in the leading international Nanosciences journal ACS Nano.
